Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center in Houston

TheNewsWire October 8, 2020

Ventripoint Announces Appointment to the Board of Directors and Option Grants

TheNewsWire September 30, 2020

Ventripoint Remotely Installs Whole Heart Analysis System in Major European Hospital

TheNewsWire September 28, 2020

Correction: Options at exercise price of $0.10. Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services

TheNewsWire September 25, 2020

Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services

TheNewsWire September 25, 2020

IIROC Trading Resumption - VPT

Canada NewsWire September 24, 2020

Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020

TheNewsWire September 23, 2020

Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading

TheNewsWire September 15, 2020

Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement

TheNewsWire September 14, 2020

Ventripoint Announces Appointment of Chief Finance Officer

TheNewsWire June 3, 2020

Ventripoint Announces Postponement of First Quarter Filings

TheNewsWire May 29, 2020

Ventripoint Announces Closing of First Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement and Exchange of Existing Debentures and Repricing and Extension of the Associated Warrants

TheNewsWire February 10, 2020

Ventripoint Provides Corporate Update and Announces $1,220,000 Non-Brokered Debenture Unit Private Placement and Exchange of Existing Debentures and Repricing and Extension of the Associated Warrants

TheNewsWire January 28, 2020

Ventripoint Clarifies News Release of December 17, 2019

TheNewsWire December 19, 2019

Ventripoint Diagnostics Provides Corporate Update

TheNewsWire December 18, 2019

IIROC Trading Halt - VPT

Canada NewsWire December 12, 2019

Ventripoint Diagnostics to Exhibit at Radiological Society of North America's 105th Scientific Assembly and Annual Meeting

TheNewsWire November 29, 2019

Ventripoint Announces Appointment of Justin Leushner as CEO and Changes to the Board of Directors

TheNewsWire November 4, 2019

IIROC Trading Resumption - VPT

Canada NewsWire October 17, 2019

Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System

TheNewsWire October 17, 2019